Tilray, Inc. Reports Fourth Quarter and Full Fiscal Year 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Eight Capital Downgrades Tilray (TLRY) to Neutral
March 3, 2020 6:42 AM ESTEight Capital analyst Graeme Kreindler downgraded Tilray (NASDAQ: TLRY) from Buy to Neutral with a price target of $17.00 (from $26.00).
For an analyst ratings summary and ratings history on Tilray click here. For more ratings news on Tilray click here.
Shares of Tilray closed at $13.80 yesterday.
... MoreTilray, Inc. (TLRY) Misses Q4 EPS by 27c, Revenues Miss
March 2, 2020 4:11 PM ESTTilray, Inc. (NASDAQ: TLRY) reported Q4 EPS of ($0.62), $0.27 worse than the analyst estimate of ($0.35). Revenue for the quarter came in at $46.94 million versus the consensus estimate of $55.38 million.
Fourth Quarter 2019 Financial Highlights
Revenue increased 202.2% to $46.9 million (C$61.0 million), compared to the fourth quarter of last year, driven by the Canadian adult-use market, the Manitoba Harvest acquisition, and growth in international medical markets. The Company recorded reserves of $4.2 million related to discounts and returns.Total cannabis kilogram equivalents sold increased over seven-fold to 15,039 kilograms from... More